Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Mar 28, 2023, before the open
10-K filed Mar 29, 2023, 88 days after period end · 0001628280-23-009583
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | $5.23M | $13.88M | — | — |
| Net Income | -$13.91M | -$15.99M |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| $8.02M |
| -$4.45M |
| EPS Diluted | — | — | — | -$0.11 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.